Ropeginterferon alfa-2b Completed Phase 3 Trials for Polycythemia Vera (PV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01949805Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera
NCT02523638Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients